Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-02-26 @ 9:57 AM
Study NCT ID:
NCT03595059
Status:
COMPLETED
Last Update Posted:
2025-12-10
First Post:
2018-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Cancer | View |
| None | Advanced Solid Tumors | View |
| None | Relapsed and/or Refractory Solid Tumors | View |
| None | ABBV-155 | View |
| None | Taxane | View |
| None | Paclitaxel | View |
| None | Docetaxel | View |
| None | breast cancer | View |
| None | non-small cell lung cancer (NSCLC) | View |
| None | small cell lung cancer (SCLC) | View |